CAPhO Hybrid Conference 2024

Program

The Conference program will feature a diverse slate of plenary concurrent, and round table sessions to engage and inform participants of the advances in oncology pharmacy. New this year is the Oral Chemotherapy Management (OCM) Workshop taking place on Thursday, April 11. 

In addition to leading-edge education, the program will include two opportunities to interact with CAPhO’s leadership during CAPhO’s Annual General and Town Hall Breakfast meetings – your chance to discuss relevant questions affecting the association. And, as always, there will be a number of sponsored symposia taking place as well as networking events with the Welcome Reception on Friday evening and the CAPhO Dinner on Saturday evening. 

Click here for a sneak preview of the Conference’s Opening Plenary featuring Françoise Mathieu's presentation, "The Edge of Compassion: Staying Well While Working in Oncology".  Information on the rest of the program (other plenaries, concurrent sessions, round tables) will be available in October.

The program will be accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP). 

Click here to download the Program at a Glance.

Thursday
April 11, 2024

Oral Chemotherapy Management (OCM) Workshop
Registration
Registration open
Sponsored Symposium
Janssen - Patient Management Considerations for Bispecific Antibodies for Multiple Myeloma and the Role of the Pharmacist

More details will be posted once available.

Sponsored by Janssen

Sponsored Symposium
Merck - Technology and new tools for HCPs with the advances in immunotherapy, IO-TKIs and IO mono therapy and IO in combination with chemotherapy

More details will be posted once available.

Sponsored by Merck

Friday
April 12, 2024

Registration
Registration open
Sponsored Symposium
TBA

More details will be posted once available.

Sponsored Symposium
Pfizer Canada - Hot Topics and Updates in Oncology

More details will be posted once available.

Sponsored by Pfizer Canada

Sponsored Symposium
AstraZeneca & Daiichi Sankyo - Managing HR+ Breast Cancer: Expert Panel Considerations in optimizing the Patient Journey

More details will be posted once available.

Sponsored by AstraZeneca and Daiichi Sankyo

Sponsored Symposium
AbbVie Corporation - Sponsored Symposium

More details will be posted once available.

Sponsored by AbbVie Corporation

Sponsored Symposium
Lilly - Beyond the Basics: Strategies for Counseling and Managing Adverse Events Associated with Adjuvant CDK4/6 Inhibitor Therapy in Early Breast Cancer.

A Medical Oncologist will do an overview of new data, counseling patients on the risk/benefits of CDK4/6 inhibitor use in early breast cancer (EBC) and the importance of establishing clear expectations in setting patients up for successful adherence.
A patient case will be presented, and a multidisciplinary panel will discuss strategic ways to counsel, educate, and manage adverse events of CDK4/ inhibitors in EBC.


The goal is to share a collaborative approach towards improving outcomes and managing patients on adjuvant CDK4/6 inhibitor treatment.

Sponsored by Lilly

Sponsored Symposium
BeiGene - New advances in indolent lymphomas: The role of pharmacists in optimizing patient outcomes

More details will be posted once available.

Sponsored by BeiGene

Sponsored Symposium
Gilead - Lines of Progress in Metastatic Triple-Negative Breast Cancer: Case-Based Applications Through a Pharmacist’s Perspective.

Join us for an interactive discussion on the Lines of Progress in Metastatic Triple-Negative Breast Cancer: Case-Based Applications Through a Pharmacist’s Perspective. Tailored to advancing insights into side effect management through clinical cases from an academic and community setting, the goal is to enhance patient outcomes through multi-disciplinary efforts to individualize care for those confronting metastatic TNBC.

Sponsored by Gilead

 

Networking session
Welcome Reception - Exhibits and Posters Viewing

Saturday
April 13, 2024

Registration
Registration open
Sponsored Symposium
Pfizer Canada - The Pharmacist’s View: New Horizons in Multiple Myeloma Management

More details will be posted once available.

Sponsored by Pfizer Canada

Break
Coffee and pastries amongst the Exhibits and Posters
Plenary session
Welcome Remarks by CAPhO and Elder
Plenary session
The Edge of Compassion: Staying Well While Working in Oncology
Presenters
Françoise Mathieu
Photo of Françoise Mathieu
Photo of Françoise Mathieu
Françoise Mathieu

Françoise Mathieu is a Registered Psychotherapist in the province of Ontario with over 25 years of experience in the field of mental health and crisis intervention. She is a nationally recognized subject matter expert on secondary traumatic stress and burnout. Françoise is the author of The Compassion Fatigue Workbook, founding member of the Secondary Traumatic Stress Consortium, and the Executive Director of TEND Academy Ltd., an organization that works with individuals and teams providing education, tools, and resources to help manage the effects of high-stress and traumaexposed work.

Françoise Mathieu

Presentation Summary:
Many who choose to work in the field of oncology pharmacy have described it as both deeply rewarding and, at times, emotionally challenging. This erosion can be further magnified by limited resources, overwork and “red tape.” However, it is possible to learn how to remain present and compassionate. This keynote will explore tools to rapidly return to a healthy baseline while working in challenging work settings such as oncology.

Participants will learn:
1. Why it’s time to stop using the term “compassion fatigue”
2. Dual awareness to remain calm and fully engaged during a stressful event
3. Strategies for daily Resetting

Break
Refreshment Break amongst the Exhibits and Posters
Plenary session
Transforming Cancer Care: Pharmacists at the Helm of Common Sense Oncology
Presenters
Bernard Marini
Photo of Bernard Marini
Photo of Bernard Marini
Bernard Marini

Bernard Marini, PharmD, BCOP is a Clinical Pharmacist specialist in Hematology and Clinical Associate Professor at the University of Michigan College of Pharmacy. He completed Pharmacy School, a PGY1 Pharmacy Practice Residency, and a PGY2 Hematology/Oncology Pharmacy at the University of Michigan, thereafter taking a position as the inpatient hematology clinical pharmacist at U of M in 2014. In his clinical practice, he takes care of patients with acute leukemias, aggressive lymphomas, and other hematologic malignancies. He is heavily involved in research aiming to improve outcomes in patients with hematologic malignancies and has over 75 peer-reviewed publications. Dr. Marini is also one of the founding members of the global Common Sense Oncology movement. In his spare time, he enjoys coaching his two daughters’ hockey and lacrosse teams, brewing very average beer, and doing his worst Auston Matthews impression on the ice for his local hockey team.

Bernard Marini

Presentation Summary:
The field of oncology is in need of a fundamental re-calibration, shifting towards a more patient-centered and equitable approach to cancer care, and pharmacists are poised to play a critical role in this movement. The Common Sense in Oncology (CSO) movement seeks to address this imperative by advocating for a patient-centric paradigm that prioritizes improved patient-clinician communication, accessible and affordable treatments, and outcomes that enhance both survival and quality of life. While some oncology therapies provide large benefits, many of them do not help patients to live longer or better lives. It is important to identify treatments which do not improve survival or quality of life because they have clinical side-effects, cause financial burden to patients, families, and health systems, and lead to lost time for patients spent in the cancer center rather than with friends and family. This session will review the need for a patient-centered approach to care, describe some of the systemic factors that have contributed to the current problems, and review ways in which pharmacists can play a major role in transforming cancer care.

Learning Objectives:
At the conclusion of this presentation, participants will be able to:
1. Explain the need for a patient-centered approach in cancer care and research
2. Summarize the rationale, mission, vision, and guiding principles of the Common Sense Oncology (CSO) movement
3. Discuss ways pharmacists can engage with and contribute to the CSO movement

CAPhO Annual General Meeting
Break
Networking Lunch amongst the Exhibits and Posters
Plenary session
Impact of Exercise on Cancer Outcomes and How This Can Inform Supportive Cancer Care in Canada
Presenters
Kristin Campbell
Photo of Kristin Campbell
Photo of Kristin Campbell
Kristin Campbell

Kristin Campbell, BSc, PT, PhD is a licensed physical therapist and a Professor in the Department of Physical Therapy at the University of British Columbia in Vancouver, Canada. She also an Affiliated Scientist in the Cancer Control Program at the BC Cancer Research Institute. Her research focus is on the role of exercise in cancer rehabilitation and survivorship She has published over 150 peer review papers, and she was the co-lead of the 2019 exercise guidelines for cancer survivors from the American College of Sports Medicine.  She is a member of the Oncology Division of the Canadian Physiotherapy Association and a Fellow of the American College of Sports Medicine.  

Kristin Campbell

Presentation Summary:
In 2019, updated international exercise guidelines for people living with and beyond cancer were published. With this there are increasing calls to implement exercise programming as part of standard of cancer care.  However, to support the call for implementation there is interest in understanding the effect of exercise on clinical outcomes, such as survival or treatment completion rate, as well as evidence of savings to the health care system.  This talk will highlight the available evidence for effect of exercise on clinical outcomes, and discuss implementation efforts nationally and internationally, including how the oncology pharmacy team can play a role.  

Learning Objectives:
1. Recognize the current recommendations for exercise manage common side effects of cancer treatment
2. Describe the research literature on the impact of exercise on survival outcomes, treatment completion rate, healthcare utilization and other clinical outcomes. 
3. Explain the current approach of supportive care in Canada to help to address these clinical outcomes
4. Examine the potential of the pharmacy in oncology team members to assist with connecting patients to supportive care resources in their area

Plenary session
Awards
Concurrent session
Overview of the Interactive Patient Communication Portal Pilot Project within Quebec to Proactively Identify and Manage Toxicity of Anti-Cancer Therapies
Presenters
Thomas Joly-Mischlich
Photo of Thomas Joly-Mischlich
Photo of Thomas Joly-Mischlich
Thomas Joly-Mischlich
Pharmacist, Pharmacy, CIUSSS de l'Estrie - CHUS — Sherbrooke, Quebec
Thomas Joly-Mischlich is an oncology pharmacist at CIUSSS de l’Estrie – CHUS in Sherbrooke, Qc. He received his Bachelor of Science in Pharmacy and his Master degree in advanced pharmacotherapy from the Université de Montréal in 2010 and 2011 respectively. He is working as an oncology pharmacist and as an associate professor of Sherbrooke University Medecine Faculty. During the last years, he led key projects in Quebec surrounding oral therapy pharmaceutical care and Patients Reported Outcome. He is also the lead investigator on the Onco-Expert project that developed an oncology protocol prescription and management software used in Quebec.
Thomas Joly-Mischlich
CIUSSS de l'Estrie - CHUS, Sherbrooke, Quebec

Presentation Summary:
The interactive patient communication portal project is a pilot project to incorporate routinely assessed patient reported outcomes to proactively identify and manage toxicity for oral anti-cancer therapies.  We used the Quebec telehomecare platform already deployed across the province to create symptom tracking algorithms and have personalized this monitoring based on prescribed therapies and the cancer associated with them. More than 200 patients used this platform during the year of the pilot project and this project highlighted the very high relevance of offering this type of monitoring to this population. The result of this pilot project will be presented during this conference.

Learning Objectives:
1. Describe the interactive patient communication portal project
2. Recognize the type of patients who could benefit from such approach 
3. List the key steps in establishing and implementing this platform and describe some of the possible challenges
4. Discuss potential future direction for this kind of follow-up strategy

Concurrent session
Steps to Successfully Standardize Oncology Preparation Processes
Presenters
Aimee Kohler
Photo of Aimee Kohler
Photo of Aimee Kohler
Aimee Kohler

Aimee Kohler is a Pharmacy Technician and Acting Regional Compounding Supervisor for Horizon Health in New Brunswick. Embracing responsibility, Aimee fosters a sense of integrity, and is a catalyst for positive change.  Her biggest accomplishments during her pharmacy career are earning her Lean Six Sigma Green Belt and creating and implementing a NAPRA compliant non-sterile compounding program in Horizon Health pharmacies. When not immersed in the world of pharmacy, you’ll likely find Aimee outside. Her idea of a wild night consists of swatting mosquitos and convincing her son there’s not a vicious animal outside the tent.

Aimee Kohler

Presentation Summary:
This presentation is centered around the concept of standardizing Oncology Preparation Processes using a structured problem-solving methodology to achieve optimal excellence. Join Aimee through her journey as she explores the why, what, and how of standardization while uncovering key steps to streamline and elevate workflow and efficiency.

Learning Objectives:
At the conclusion of this presentation, participants will be able to:
1. List the benefits of standardization in Oncology preparation processes, allowing them to make informed decisions when considering standardization 
2. Identify tools available to assist with process improvement and change management, fostering a proactive approach to continuous improvement
3. Analyze and evaluate oncology preparation data/reports, empowering them to make data-driven decisions
4. Plan and implement effective change within the workplace, enabling them to lead initiatives that have a positive impact on the organization

Concurrent session
Oral Anti Cancer Drugs - Pharmacy Strategies to Promote Safe and Integrated Community Care
Presenters
Joy Rashid
Mova Leung
Photo of Joy Rashid
Photo of Joy Rashid
Joy Rashid

Joy is a graduate of the University of Manitoba BSc. Pharmacy program in 2011 after which she worked at the St. Boniface Hospital in Winnipeg for two years. She completed a hospital residency program at The Ottawa Hospital in 2014 and has worked there since then, specializing in inpatient malignant hematology. Most recently, Joy has shifted to a primarily outpatient-based practice in her role as a Hematology Program Coordinator at Extend Pharmacy, an oncology focused community pharmacy. She has taken on roles as a pharmacy preceptor, OSCE assessor, past member of the CAPhO Education Committee, contributed to research residency projects and participated in an international mission/preceptorship with Pharmacists Without Borders. 

Joy Rashid
Photo of Mova Leung
Photo of Mova Leung
Mova Leung
Oncology Pharmacy Practitioner, Oncology, North York General Hospital — North York, Ontario
Mova is the Oncology Clinical Pharmacy Practitioner at North York General Hospital. She leads and promotes the clinical activities of the oncology pharmacy team, and drug utilization for the Cancer Care program. She is also Course Coordinator and Adjunct Lecturer of the Hematology, Oncology and Immunotherapy course at the University of Toronto’s Faculty of Pharmacy. Mova Leung graduated from the University of Toronto with her BSCPhm, then a PharmD and subsequently completed a Pharmacy Practice residency. She also holds her Board Certification in Oncology. She is the Oncology Clinical Pharmacy Practitioner at North York General Hospital and Adjunct Lecturer at the University of Toronto’s Faculty of Pharmacy. At NYGH, she leads and promotes the clinical activities of the oncology pharmacy team, drug utilization, and drug access navigation for the Cancer Care program. Working closely with oncologists and hematologists, the Allied Health team, and Palliative Care, she strives to optimize patient care. At the Faculty of Pharmacy, Mova is course coordinator and lecturer for the Oncology, Hematology and Immunology course. Her other professional activities include precepting, publishing, research and involvement in institutional, regional, and national oncology committees.
Mova Leung
North York General Hospital, North York, Ontario

Presentation Summary:
With the rise of oral anti-cancer drugs (OACDs) the roles and responsibilities of community pharmacists and specialty oncology pharmacies are growing.  OACDs are often prescribed as part of more complex regimens and in populations with a myriad of comorbidities and concurrent drug therapies.  Learn about the challenges faced by community pharmacists, the role of specialty pharmacies and the importance of collaboration between health care providers, to optimize safety of OACDs. Explore the barriers faced when trying to engage community pharmacies and come prepared to discuss strategies to narrow the care gap and manage this complex population.

Learning Objectives:
1. Recognize the challenges faced by community pharmacists in triaging oral anti-cancer therapies.
2. Using case-based examples:
        a) Describe the role of specialty oncology pharmacies in bridging the gap between hospital and community cancer care to optimize safety of oral anti-cancer drugs.
        b) Illustrate the need for collaboration and engagement between primary prescribers, pharmacists and patients to provide integrated holistic patient-centered care. 
3. Discuss opportunities and barriers in engaging the patient's community pharmacy by reviewing the results of the Community Pharmacy Engagement Initiative (CPEI).
4. Propose strategies to narrow the gap created by having drugs dispensed in multiple pharmacies.

Concurrent session
Improving Chemotherapy Safety in a Ugandan Hospital - A Personal Experience
Presenters
Tara Leslie
Photo of Tara Leslie
Photo of Tara Leslie
Tara Leslie
Clinical Associate Professor and Clinical Pharmacist, Pharmacy, University of Alberta — Calgary, Alberta
Dr. Tara Leslie is a Clinical Associate Professor with the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta. She is also the Director for the Certificate to Canadian Pharmacy Practice program. Tara teaches oncology related curriculum to learners in a variety of courses and programs with The Faculty and maintains a clinical practice in hematology at the Tom Baker Cancer Center in Calgary. Tara’s credentials include Board Certification in Oncology Pharmacy, a Masters of Education in Health Sciences Education and a post-professional PharmD. As part of Tara’s PharmD experiential education, Tara travelled to northern Uganda where she collaborated with pharmacy and oncology staff at St. Mary’s hospital to improve chemotherapy safety processes and deliver care to pediatric oncology patients.
Tara Leslie
University of Alberta, Calgary, Alberta

Session Description: 
Rapidly progressive, pediatric, Burkitt Lymphoma is an endemic health concern in many sub-Saharan African countries.  Optimal outcomes are complicated by many of the challenges Canadians might expect such as a lack of modern diagnostics and the limited treatment options afforded by the WHO essential medicines list.    However, additional difficulties such as poor recognition of a malignant process leading to late presentation, limitations in supportive care measures, malnutrition, practicality of a parent’s extended stay, and various chemotherapy safety concerns also exist.  

Session Learning Outcomes: 
By the end of this session, the attendee will be able to: 
1. Appreciate the various types of resource limitations that exist in a remote hospital within a low or low-middle income country. 
2. Describe the impact to care for cancer patients when resources are limited 
3. Explain opportunities to improve chemotherapy safety for patients, family, and staff in under-resourced hospitals
4. Critically reflect on the privileges in our practice and health care system that we may have under-recognized in the past
 

Break
Refreshment Break amongst the Exhibits and Posters
Concurrent session
The Balancing Act of Cardio-Oncology
Presenters
Sheri Koshman
Photo of Sheri Koshman
Photo of Sheri Koshman
Sheri Koshman
BScPharm, PharmD, ACPR, FCSHP

Dr. Koshman is an Associate Professor of Medicine with the Division of Cardiology at the University of Alberta, in Edmonton.  She practices in the Heart Function Clinic and the Cardio-Oncology Clinic at the Mazankowski Alberta Heart Institute. She is the co-lead of the first Advanced Pharmacy Residency Cardiology program in Canada. She teaching in the cardiology blocks for both the Faculty’s of Medicine and Dentistry and Pharmacy and Pharmaceutical Sciences and is a clinical preceptor for both PharmD students and pharmacy residents. 
Dr. Koshman is a former member of the Canadian Cardiovascular Heart Failure Guidelines Committee, is a member of the Alberta Health Services Strategic Clinical Network Heart Failure Working Group and co-developer of the Med-HF App, a heart failure app aimed at helping front line practitioner manage heart failure medications. 
She was one of the first 15 pharmacists to be awarded independent prescribing rights in Canada. 

Sheri Koshman

Presentation Summary:
Cardio-oncology is a subspecialty of care dedicated to the prevention, identification and treatment of cardiovascular complications in patients undergoing cancer therapy and long-term cancer survivors.  In this session, using a case-based approach, we will walk through common scenarios of cancer therapies that may cause cardiovascular toxicity (CVT) and strategies to prevent and treat these, with the goal of preventing cancer treatment interruptions.

Learning Objectives:
At the conclusion of this activity, participants will be able to discuss:
1. the use of OAC with BTK inhibitor therapy
2. the role of cardio-protection prior to and during anthracycline therapy
3. the role of cardio-protection in HER-2 therapy

Concurrent session
Oncology Pharmacy -  On the Front Line of a Climate Crisis
Presenters
Shellyza Sajwani
Photo of Shellyza Sajwani
Photo of Shellyza Sajwani
Shellyza Sajwani
Pharmacist, Pharmacy, Ottawa Hospital — Gloucester, Ontario
Shellyza Sajwani is a pharmacist who works within areas of oncology, global health and climate change as they relate to the pharmacy profession. Shellyza received her MPharm from Aston University in the UK, her PharmD from the University of Toronto and her Climate Change and Health certification from Yale University. She is the national co-chair of the new Canadian Association of Pharmacy for the Environment (CAPhE) and is also the co-chair of the Ottawa Hospital Pharmacy Environmental Committee. Shellyza also co-chaired the International Pharmaceutical Federation (FIP) policy committee which created and passed the first ever international pharmacy climate change policy in 2023. She is currently the co-founder of Climaceutics Health Solutions which focuses on building a tool and certification process for pharmacies to reduce their emissions and improve their climate resilience. Shellyza also has experience working as the previous co-president of Pharmacists Without Borders Canada and as an oncology pharmacy consultant in Gulu, Uganda in 2017 and 2018. She has also worked for several years as an oncology pharmacist at the Ottawa Hospital, with eight years of experience in a combination of outpatient and inpatient oncology. Finally, Shellyza is an ovarian cancer survivor, and has worked with organizations such as Young Adult Cancer Canada and Ovarian Cancer Canada in advocating for cancer patients.
Shellyza Sajwani
Ottawa Hospital, Gloucester, Ontario

Presentation Summary:
This presentation examines how pharmacy professionals are already on the front line of the climate crisis, and how climate-conscious oncology pharmacists can significantly improve patient care. Participants will gain insights into the impact of climate change on health, particularly in the context of cancer and chemotherapy . The session will also discuss practical climate mitigation strategies, including examples relevant to deprescribing. Additionally, this session will also equips attendees with skills for the basics of climate adaptation within oncology pharmacy, focusing on emergency preparedness and clinical medication management during heat waves. This presentation will also provide next steps for pharmacy professionals interested in learning more, and conclude with a summary of how climate change affects supply chain considerations within the oncology pharmacy landscape.

Learning Objectives:
1. Develop an understanding of how climate change impacts health and cancer, specifically exploring the direct and indirect effects on patients receiving oncology medications
2. Explain how the awareness of climate change hazards can influence practical clinical decision making within oncology pharmacy, particularly related to climate adaptation
3. Explain how pharmacy professionals are at the forefront of the climate crisis, and how they can reduce emissions within their own day to day practice

Concurrent session
A Primer on Artificial intelligence for Oncology Pharmacists
Presenters
Sean Hopkins
Sean Hopkins
Senior Program Advisor, PDRP, Cancer Care Ontario — Barrie, Ontario
Sean Hopkins
Cancer Care Ontario, Barrie, Ontario

Presentation Summary:
Artificial Intelligence (AI) is revolutionizing oncology pharmacy by enhancing precision medicine, optimizing treatment plans, and improving patient outcomes. By analyzing vast datasets, AI algorithms can identify patterns and predict drug responses, enabling personalized therapy. It assists in drug discovery by rapidly screening compounds and predicting their effectiveness against specific cancer types. Moreover, AI streamlines workflow by automating medication management and monitoring, reducing errors, and ensuring compliance. For oncology pharmacists, AI offers tools for better decision-making, supports clinical research, and fosters a deeper understanding of cancer pharmacotherapy. This technological advancement promises a future where cancer treatment is more targeted, effective, and patient-centric.

Learning Objectives:
At the end of this presentation, attendees will be able to:
1. Understand the Fundamentals of AI in Oncology 
2. Demonstrate the Application of AI in Personalized Medicine
3. Describe AI-Driven Drug Discovery and Development
4. Assess Ethical Considerations and Patient Safety
5. Propose how to navigate Navigating the Future of Oncology Pharmacy with AI  or to propose a strategy to navigate

Concurrent session
Implementation of an IV Workflow Solution for NAPRA Compliant Sterile Compounding across BC Cancer Pharmacies
Presenters
Kimberly Kuik
Neil de Haan
Photo of Kimberly Kuik
Photo of Kimberly Kuik
Kimberly Kuik
BScPharm
Pharmacy Professional Practice Leader, Pharmacy, BC Cancer — Victoria, British Columbia
Kimberly Kuik is the Pharmacy Professional Practice Leader at BC Cancer – Victoria. As the pharmacy leader, she is responsible for the pharmacy operations at her centre which include sterile product preparation, ambulatory oncology pharmacy activities, implementing new treatment options and support for clinical trials. Kimberly has been involved in many provincial BC Cancer Pharmacy Initiatives. She participated in the Oral Chemotherapy task force at BC Cancer and has special interest in developing follow-up protocols for patients on treatment at home. As well, Kimberly represented BC on the Clinical Operations Working group of the pan-Canadian Oncology Biosimilar Initiative and served on the BC Cancer Biosimilars Steering Committee. Most recently, she was the Clinical Operation Lead for BC Cancer’s implementation of an IV Workflow Solution across its pharmacies.
Kimberly Kuik
BC Cancer, Victoria, British Columbia
Photo of Neil de Haan
Photo of Neil de Haan
Neil de Haan
Coordinator, Provincial Pharmacy Information Systems, Provincial Pharmacy, BC Cancer — Vancouver, British Columbia
Neil de Haan is a Provincial Pharmacy Information Systems Coordinator at BC Cancer. Working with the Provincial Health Services Authority IT department (PHSA PDHIS), he is responsible for the selection, implementation, and maintenance of optimal pharmacy-managed computer systems for the six (6) regional cancer centres, Provincial Pharmacy, and the Provincial Systemic Therapy Program. He plans, develops, maintains, and supervises education and information for the implementation and ongoing utilization of these systems. Neil has a keen interest in Human Computer Interaction (HCI), Usability, Technology-Induced Error, and Medication Adherence. In his nearly 15 years with BC Cancer, Neil has been involved in many Pharmacy Informatics initiatives as a technical expert such as the implementation of a Dose Error Reduction System (smart pumps), implementation of a health-authority wide Electronic Health Record (EHR), replacement of the BC Cancer Online System for Cancer drug Adjudication and Reimbursement (OSCAR) and the Compassionate Access Program (CAP) software, and the implementation of an IV Workflow Solution.
Neil de Haan
BC Cancer, Vancouver, British Columbia

Presentation Summary:
Pharmacies across BC were required by the College of Pharmacists of BC (CPBC) to implement the National Association of Pharmacy Regulatory Authorities (NAPRA) Model Standards for Pharmacy Compounding of Hazardous and Non-Hazardous Sterile Preparations by July 1, 2022. The new standards encompass all aspects of sterile compounding and represented a significant change to pharmacy operations. New measures included annual staff competency assessments, enhanced garbing and personal protective equipment, air monitoring, surface cleaning, equipment testing, end product testing, product handling, storage, labeling, record keeping, and auditing. The implementation of the IV workflow solution addressed many aspects to ensure compliance with the standards and ultimately sterile products for safe patient care and reduced exposure to hazardous drugs for health care professionals.  An overview of the IV workflow solution components, implementation plan, activation and ongoing sustainment activities will be discussed.

Learning Objectives:
By the end of this session, participants will be able to:
1. Outline the specific components of an IV workflow solution and the corresponding benefits to pharmacy operations.
2. Assess the implementation timeline and activation processes.
3. Demonstrate an understanding of ongoing sustainment activities and lessons learned during implementation.

Running/Walking/Tidal Bore
CAPhO East Coast Kitchen Party

Sunday
April 14, 2024

Sponsored Symposium
Apotex-Apobiologix - How to Leverage Technology to Advance Oncology Patient Care and Remote Pharmacy Services + 2024 HOPE Awards
Presenters
Scott Edwards
Michael LeBlanc
Photo of Scott Edwards
Photo of Scott Edwards
Scott Edwards
Clinical Pharmacy Specialist, Pharmacy, Eastern Health — St John's, Newfoundland and Labrador
Scott Edwards is currently the Clinical Oncology Pharmacy Specialist at the Dr. H. Bliss Murphy Cancer Center in St. John’s, Newfoundland. He is also an assistant professor at the School of Pharmacy and the Discipline of Oncology, Faculty of Medicine, Memorial University of Newfoundland. He is active in clinical cancer research in the area of chemotherapy toxicities, supportive care and oral chemotherapy adherence. He graduated from Memorial University of Newfoundland with a B.Sc. (Neuroscience) in 1994 and a B.Sc (Pharmacy) in 1997. In 2005, he graduated with a Doctor of Pharmacy degree from the University of Washington. He completed a Master’s degree in Oncology from Newcastle University in 2015.
Scott Edwards
Eastern Health, St John's, Newfoundland and Labrador
Photo of Michael LeBlanc
Photo of Michael LeBlanc
Michael LeBlanc
Clinical Resource Pharmacist, Oncology, Pharmacy, Horizon Health Network — Moncton, New Brunswick
Clinical Resource Pharmacist (Oncology) providing care for patients receiving oral anti-cancer therapies.
Michael LeBlanc
Horizon Health Network, Moncton, New Brunswick

Join keynote speakers Scott Edwards and Michael LeBlanc in "Leveraging Technology for Advanced Oncology Care." Explore the tech-driven evolution in oncology pharmacy through a website/app and discover ways to enhance remote patient care. Also uncover two exciting APP initiatives: The ABC Program and the prestigious HOPE Awards. Gain insights into ABC program and how it’s evolved since 2021, and hear from 2024 HOPE Award winners about their ground-breaking projects that are driving positive change in oncology pharmacy. Don't miss this exciting session highlighting the future of patient care and innovation.

2024 HOPE Award Winners to be announced.

Sponsored by Apotex-Apobiologix

 

Registration
Registration open
CAPhO Town Hall Breakfast Meeting
CAPhO Poster Award Presentations
Plenary session
LGBTQIA+ Clinical Considerations in Cancer Care
Presenters
Maya Leiva
Photo of Maya Leiva
Photo of Maya Leiva
Maya Leiva

Maya Leiva is an Advanced Practice Pharmacist and holds a Board Certification in Oncology Pharmacy. Dr. Leiva received their pharmacy degree at Loma Linda University School of Pharmacy.  They most recently assisted the Inova health System to complete its first Health Equality Index survey. Their research interests include supportive care, LGBTQIA+ specific health needs, reducing health disparities among marginalized communities, and oncology stewardship to reduce financial toxicities to patients and health care. Dr. Leiva is affiliated with West Coast University as an Associate Professor and is the Director of Infusion Services for Bass Cancer Center in California. 

Maya Leiva

Presentation summary:
We will engage in an Interactive discussion around caring for LGBTQIA+ cancer patients from a trauma informed care perspective. We will touch on cultural humility for our richly heterogeneous, and intersectional patient community that can help empower clinicians to use appropriate language. There will be an emphasis on cancer risks and disparities related to sexual orientation and gender identity minority groups. Additionally, we will focus on clinical implications and blind spots for persons receiving gender affirming care from cancer screening, diagnosis, to treatment. 

Learning Objectives: 
1. Define the terms related to the LGBTQIA+ community, with a particular emphasis on those who are transgender and gender diverse. 
2. Describe health disparities that disproportionally affect members of the LGBTQIA+ community
3. Recall unique cancer care and screening challenges for transgender and gender diverse persons
4. Apply principles of trauma informed care when caring for LGBTQIA+ patients. 

Plenary session
Stories and Strategies to Support Oncology Pharmacy Professionals in Caring for Indigenous Peoples
Presenters
Jaris Swidrovich
Neebun Bear
Imelda Perley (Opalahsomwehs)
Photo of Jaris Swidrovich
Photo of Jaris Swidrovich
Jaris Swidrovich

Dr. Jaris Swidrovich is an Assistant Professor, Teaching Stream, and Indigenous Engagement Lead in the Leslie Dan Faculty of Pharmacy at the University of Toronto. He is a queer, Two Spirit, disabled, Saulteaux and Ukrainian pharmacist from Yellow Quill First Nation. Dr. Swidrovich is the first and only Indigenous faculty member in pharmacy in North America. 
He received a Bachelor of Science in pharmacy and PhD in education from the University of Saskatchewan and a postbaccalaureate Doctor of Pharmacy from the University of Toronto. His primary areas of research and practice include pain, HIV/AIDS, harm reduction, 2SLGBTQ+ health, and Indigenous health. 

Jaris Swidrovich
Photo of Neebun Bear
Photo of Neebun Bear
Neebun Bear

Project Support Manager for Kmawuhsahtipon Togi Pematioog (KTMF) First Nation Cancer Care Plan for all Indigenous in New Brunswick
Registered Social Worker

Neebun Bear
Photo of Imelda Perley (Opalahsomwehs)
Photo of Imelda Perley (Opalahsomwehs)
Imelda Perley (Opalahsomwehs)

Opolahsomuwehs (Moon of the Whirling Wind) also known as Imelda Perley is Wolastoqew, and presently works as Community Language Coordinator for Neqotkuk. She is also Cultural Consultant for two Health Canada initiatives within the Maternal Child Health program and the Maliseet Nation Mental Wellness program. Her traditional roles within the community include Sweatlodge Keeper, Medicine Wheel Teacher, Sacred Pipe Carrier, and Keeper of the Women’s Ceremonies. Imelda holds a BA specializing in Linguistics and M Ed both from University of New Brunswick. She was awarded a honorary doctorate of letters degree from University of New Brunswick for her “incredible work contributing to the support, education and visibility of Indigenous peoples at UNB and across the province”.

Imelda Perley (Opalahsomwehs)

Presentation Summary:
This plenary will address disparities in care for First Nations, Métis, and Inuit and ways that oncology pharmacy professionals can help bridge the gap to provide patient centred care to this population. Real life experiences within the cancer care system in Canada will be discussed, including what works, challenges, what can be improved, and what strategies are currently underway to address Indigenous cultural safety within cancer care across Canada.

Learning Objectives:
1. Describe the differences in terminology used to describe and differentiate Indigenous Peoples in Canada.
2. Summarize the determinants of Indigenous Peoples’ health in Canada and describe their relation to cancer among Indigenous Peoples.
3. Examine real life experiences of Indigenous Peoples in the cancer care system in Canada.
4. List strategies for pharmacy professionals to improve the cancer care experience for Indigenous Peoples in Canada.

Plenary session
Closing Remarks
Round table discussion
Pharmacy Technician Leaders: A Roundtable Conversation of Opportunity and Motivation
Presenters
Aimee Kohler
Photo of Aimee Kohler
Photo of Aimee Kohler
Aimee Kohler

Aimee Kohler is a Pharmacy Technician and Acting Regional Compounding Supervisor for Horizon Health in New Brunswick. Embracing responsibility, Aimee fosters a sense of integrity, and is a catalyst for positive change.  Her biggest accomplishments during her pharmacy career are earning her Lean Six Sigma Green Belt and creating and implementing a NAPRA compliant non-sterile compounding program in Horizon Health pharmacies. When not immersed in the world of pharmacy, you’ll likely find Aimee outside. Her idea of a wild night consists of swatting mosquitos and convincing her son there’s not a vicious animal outside the tent.

Aimee Kohler
Round table discussion
Implementation of KPIs - How Ready Are We?
Presenters
Michael LeBlanc
Tom McFarlane
Photo of Michael LeBlanc
Photo of Michael LeBlanc
Michael LeBlanc
Clinical Resource Pharmacist, Oncology, Pharmacy, Horizon Health Network — Moncton, New Brunswick
Clinical Resource Pharmacist (Oncology) providing care for patients receiving oral anti-cancer therapies.
Michael LeBlanc
Horizon Health Network, Moncton, New Brunswick
Tom McFarlane
Tom McFarlane
Round table discussion
Asparaginase Formulations and How to Implement Various Products
Presenters
Melissa Lo
Melissa Lo
Melissa Lo
Round table discussion
The Role of the Pharmacy Technician in Informatics/IMITs
Presenters
Hailey Hil
Hailey Hil
Hailey Hil
Round table discussion
Best Practices for Managing Infusion-Related Reactions (IRR) with Anti-Cancer Therapy and How to Develop a Proactive Service to Optimize IRR Prevention
Presenters
Marc Geirnaert
Marc Geirnaert
Marc Geirnaert
Round table discussion
Survivorship and the Role of Pharmacy Professionals in Pediatric and Adult Settings
Presenters
Nikki Blosser
Photo of Nikki Blosser
Photo of Nikki Blosser
Nikki Blosser
Clinical Practice Leader, Pharmacy, Tom Baker Cancer Centre — Calgary, Alberta
I graduated from Memorial University in 2010 and then moved to Calgary to complete a pharmacy residency with a focus in oncology. Since that time I have been working as a clinical pharmacist in the BMT program at the Tom Baker Cancer Centre and served as the interim clinical research pharmacist in the hematology, oncology and transplant clinic at Alberta Children’s Hospital. I am currently a Clinical Practice Leader for ambulatory oncology and rural pharmacy teams and chair of CAPhO's Education Committee, Pharmacists - Advanced. I have an interest in survivorship and enjoy participating in research projects with the BMT long term follow-up clinic.
Nikki Blosser
Tom Baker Cancer Centre, Calgary, Alberta
Round table discussion
The Pressures when Feeling the Pressure in the Work Force
Presenters
Terri-Lynn Kingston
Terri-Lynn Kingston
Terri-Lynn Kingston
Round table discussion
Preparing for a Career in Hematology/Oncology Pharmacy Practice
Presenters
Jacqueline Richard
Meagan London
Jacqueline Richard
Pharmacist, Pharmacy, Horizon Health Network — Saint John, New Brunswick
Jacqueline Richard
Horizon Health Network, Saint John, New Brunswick
Meagan London
Pharmacist, Oncology, Horizon Health Network — Rothesay, New Brunswick
Meagan London
Horizon Health Network, Rothesay, New Brunswick